Loading...
XNAS
OFIX
Market cap427mUSD
Jun 04, Last price  
10.90USD
1D
-1.18%
1Q
-35.12%
Jan 2017
-69.87%
Name

Orthofix Medical Inc

Chart & Performance

D1W1MN
P/E
P/S
0.53
EPS
Div Yield, %
Shrs. gr., 5y
15.07%
Rev. gr., 5y
11.69%
Revenues
799m
+7.08%
313,304,000365,359,000490,323,000519,675,000545,635,000564,370,000578,988,000462,320,000400,534,000402,277,000396,489,000409,788,000433,823,000453,042,000459,955,000406,562,000464,479,000460,713,000746,641,000799,491,000
Net income
-124m
L-18.18%
73,402,000-7,042,00010,968,000-228,554,00024,472,00044,208,000-1,073,00051,295,000-28,475,000-8,537,000-2,809,0003,056,0006,223,00013,811,000-28,462,0002,517,000-38,379,000-19,749,000-151,395,000-123,875,000
CFO
26m
P
106,673,0008,171,00021,496,00026,770,00049,970,00042,474,00064,781,00011,206,00067,445,00050,958,00043,224,00044,707,00053,341,00049,918,00032,033,00074,272,00018,475,000-11,538,000-45,753,00025,790,000
Earnings
Aug 04, 2025

Profile

Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
IPO date
Apr 24, 1992
Employees
1,092
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
799,491
7.08%
746,641
62.06%
460,713
-0.81%
Cost of revenue
327,249
870,994
481,385
Unusual Expense (Income)
NOPBT
472,242
(124,353)
(20,672)
NOPBT Margin
59.07%
Operating Taxes
2,122
2,716
2,043
Tax Rate
0.45%
NOPAT
470,120
(127,069)
(22,715)
Net income
(123,875)
-18.18%
(151,395)
666.60%
(19,749)
-48.54%
Dividends
Dividend yield
Proceeds from repurchase of equity
6,257
5,127
2,608
BB yield
-0.94%
-1.04%
-0.63%
Debt
Debt current
4,778
5,435
652
Long-term debt
197,463
151,481
39,130
Deferred revenue
11,297
Other long-term liabilities
46,692
32,598
18,906
Net debt
119,003
123,809
84,390
Cash flow
Cash from operating activities
25,790
(45,753)
(11,538)
CAPEX
(34,876)
(60,256)
(23,160)
Cash from investing activities
(27,580)
(33,131)
(24,534)
Cash from financing activities
50,709
65,322
(78)
FCF
529,898
(340,715)
(65,575)
Balance
Cash
83,238
33,107
50,700
Long term investments
(95,308)
Excess cash
43,263
Stockholders' equity
(272,292)
(147,720)
1,891
Invested Capital
1,001,736
913,247
380,368
ROIC
49.10%
ROCE
64.74%
EV
Common stock shares outstanding
38,134
36,729
20,054
Price
17.46
29.53%
13.48
-34.34%
20.53
-33.97%
Market cap
665,814
34.48%
495,110
20.26%
411,699
-32.75%
EV
784,817
618,919
496,089
EBITDA
548,243
(63,755)
11,403
EV/EBITDA
1.43
43.51
Interest
29,631
8,631
1,288
Interest/NOPBT
6.27%